WO2007007828A1 - Ethylenediamine derivative and method for producing same - Google Patents
Ethylenediamine derivative and method for producing same Download PDFInfo
- Publication number
- WO2007007828A1 WO2007007828A1 PCT/JP2006/313933 JP2006313933W WO2007007828A1 WO 2007007828 A1 WO2007007828 A1 WO 2007007828A1 JP 2006313933 W JP2006313933 W JP 2006313933W WO 2007007828 A1 WO2007007828 A1 WO 2007007828A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- formula
- lower alkyl
- alkyl group
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
- C07D301/24—Synthesis of the oxirane ring by splitting off HAL—Y from compounds containing the radical HAL—C—C—OY
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
Definitions
- the present invention relates to a novel compound useful as an intermediate for the production of benzylamine derivatives and a method for producing the same.
- the benzylamine derivative represented by the following general formula (A) has excellent tachycun antagonism, particularly substance P antagonism, antagonism against neurocun A and B, and irritable bowel syndrome (IBS: Irritable Bowel Syndrome), known to be useful for the treatment of diseases such as pain, anxiety, obstructive bronchial disease, headache, vomiting (see Patent Document 1)
- Patent Document 1 discloses a process for producing a benzaldehyde derivative from a commercially available benzaldehyde via a 2-methylaminopentenol derivative.
- the synthesis method described in Patent Document 1 requires many steps, and the development of a manufacturing method that is industrially superior has been demanded.
- Patent Document 1 International Publication No. 2005Z012248 Pamphlet
- an object of the present invention is to provide a novel intermediate useful for the production of the benzylamine derivative represented by the general formula (A) and a method for producing the same.
- R 1 represents a lower alkyl group, an aryl group or an aralkyl group
- R 2 represents a lower alkyl group or an alkenyl group
- Ar may have a substituent, which may be an aryl group
- a primary amin (NH R 3 ) is reacted with the aziridine compound represented by
- R 3 represents a lower alkyl group, an aryl group or an aralkyl group which may have a substituent, R 2 and Ar are as defined above
- the present invention provides an optically resolved formula (7) characterized by optically resolving an ethylenediamine derivative represented by the formula (6) obtained by the above method or a salt thereof.
- the compound represented by the formula (4) is characterized by reacting a Grignard reagent (R 2 MgX 2 ) with a haloacetyl aryl compound represented by formula (4), and further reacting with a primary amine (NH R 1 ).
- a compound represented by formula (5) is characterized by reacting triarylphosphine and halogen in the presence of a tertiary amine.
- optically active ethylenediamine derivative represented by these, or its salt is provided.
- the invention's effect is provided.
- the benzylamine derivative can be efficiently produced with few steps, and is suitable for industrial production.
- the ethylenediamine derivative which is the compound of the present invention is useful as a pharmaceutical production intermediate because it can be isolated and purified as an optically active ethylenediamine derivative by optically resolving and crystallizing it. .
- examples of the lower alkyl represented by R 1 R 2 and R 3 include a linear or branched alkyl group having 1 to 6 carbon atoms, such as a methyl group, an ethyl group, a propyl group, Examples include isopropyl group, butyl group, t-butyl group, pentyl group, hexyl group and the like. Of these, a methyl group is particularly preferred.
- the aryl group represented by R 1 includes an aryl group having 6 to 14 carbon atoms, and examples thereof include a phenyl group and a naphthyl group.
- the aralkyl group represented by R 1 and R 3 includes C 1 -C 6 -aryl-C 1 -C 4 alkyl.
- R 1 is preferably a lower alkyl group, and particularly preferably a methyl group.
- the alkenyl group represented by R 2 includes a C-C linear or branched alkenyl group.
- Examples thereof include a vinyl group, a aryl group, a butyr group, a pentyl group, and a hexenyl group. Of these, an aryl group is particularly preferable.
- R 2 is preferably an alkenyl group, particularly preferably an aryl group.
- the aryl group having the substituent represented by R 3 include aryl groups having 6 to 14 carbon atoms as described above.
- the group that can be substituted on the aryl group include 1 to 3 groups such as a halogen atom, a nitro group, a lower alkyl group, and a lower alkoxy group.
- the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
- the lower alkyl group include linear or branched alkyl groups having 1 to 6 carbon atoms as described above.
- Examples of the lower alkoxy group include linear or branched alkoxy groups having 1 to 6 carbon atoms, such as methoxy group, ethoxy group, n propoxy group, isopropyl group, n-butoxy group, isobutoxy group, sec butoxy group, tert butoxy group, n pentyloxy group, isopentyloxy group, n-hexyloxy group, and the like.
- R 3 is preferably a lower alkyl group, and a methyl group is particularly preferable.
- the aryl group optionally having a substituent represented by Ar has the same carbon number as described above.
- Examples thereof include 6 to 14 aryl groups, preferably a phenol group.
- examples of the group that can be substituted on the aryl group include the same halogen atoms as described above, and preferably a chlorine atom.
- the number of substituents is 1 to 3, but preferably 2.
- the substitution positions are preferably the 3rd and 4th positions.
- Examples of the halogen atom represented by X 1 , X 2 , X 3 and X 4 include the same halogen atoms as described above, preferably a chlorine atom and a bromine atom.
- the attached carbon atom is an asymmetric carbon atom.
- the configuration of the asymmetric carbon may be either the R configuration or the S configuration, but the S configuration is preferred.
- the salt of the ethylenediamine derivative is not particularly limited as long as it is a pharmaceutically acceptable salt.
- acid addition salts such as hydrochloride, sulfate, nitrate, hydrobromide, p-toluenesulfonic acid, etc. Salts, methanesulfonate, fumarate, hibenzate, succinate, tartaric acid, lactate and the like.
- the ethylenediamine derivative or salt thereof of the present invention includes those solvates. Further, both optically active substances and mixtures thereof are included.
- R 1 represents a lower alkyl group, an aryl group or an aralkyl group
- R 2 represents a lower alkyl group or an alkyl group
- R 3 has a lower alkyl group or a substituent.
- Ar may be an aryl group or an aralkyl group
- Ar may have a substituent
- X 1 and X 2 represent a halogen atom
- * represents an asymmetric carbon atom.
- a compound (4) is obtained after reacting the haloacetyl aryl compound (1) with a Grignard reagent, further reacting with a primary ammine.
- the compound (4) is reacted with a triarylphosphine and a halogen atom in the presence of a tertiary amine to give an aziridine compound (5), and the compound (5) is ring-opened with the primary amine.
- Compound (6) is obtained.
- compound (6) is optically resolved to separate a desired diastereomeric salt, and the resulting diastereomeric salt is treated with a base to obtain optically active substance (7).
- the compounds (2) to (5) are useful as production intermediates of the compound (6) of the present invention.
- the compound represented by the general formula (1) which is the starting material of the present invention is a known compound. For example, it can be easily synthesized by reacting a commercially available acetophenone derivative with a halogen atom according to the method described in the fourth edition, Experimental Chemistry Course 19 (Maruzen).
- the reaction of the haloacetyl aryl compound (1) and the Grignard reagent is carried out in an ether solvent such as jetyl ether, tetrahydrofuran or dioxane.
- the Grignard reagent is preferably used in an equimolar amount with respect to compound (1).
- the reaction temperature is not particularly limited, but is usually ⁇ 110 ° C. to ⁇ 10 ° C., preferably ⁇ 80 ° C. to 40 ° C.
- the reaction time is not particularly limited, but is usually from the end of dropping to 48 hours, preferably from 0.5 to 12 hours.
- the compound (2) proceeds to the derivative (3).
- the reaction solution it may be a mixture of compounds (2) and (3), but it can be used in the next reaction without changing the reaction system.
- the compound (4) is obtained by reacting the mixture of the compounds (2) and (3) obtained by the above reaction with a primary amine.
- Examples of the primary amine used in the reaction include lower alkylamines such as methylamine and ethylamine; aralkylamines such as benzylamine; and arylamines such as aline and naphthylamine. .
- the amount of amine used is preferably 1 to 3 moles, more preferably 2 to 2.5 moles per mole of the mixture of compounds (2) and (3).
- the solvent used in the reaction is not particularly limited as long as it does not adversely affect the reaction, and examples thereof include alcohols such as methanol and ethanol; ethers such as jetyl ether, tetrahydrofuran and dioxane; water and the like. These may be used in combination.
- the reaction temperature is not particularly limited, but is preferably room temperature to 80 ° C, particularly preferably 30 ° C to 60 ° C.
- the reaction time is not particularly limited, but is usually 0.5 to 24 hours, preferably 0.5 to 12 hours.
- the synthesis of the aziridine compound (5) involves the intramolecular cyclization reaction proceeding by reacting the compound represented by the formula (4) with triarylphosphine and halogen in the presence of a tertiary amine. An aziridine ring is formed.
- Examples of the tertiary amine used in the reaction include trimethylamine, triethylamine, tri-n-butyramine, N, N-dimethylamine, and preferably triethylamine.
- the amount of the base used is preferably 2 to 6 mol, particularly preferably 3 to 4 mol, based on 1 mol of the compound (4)! /.
- triarylphosphine used in the reaction examples include triphenylphosphine.
- halogen examples include fluorine, chlorine, bromine and iodine, and bromine is preferable.
- the amount of triarylphosphine and halogen used is preferably 1 to 3 mol, particularly preferably 1.3 to 2 mol, per 1 mol of compound (4).
- the solvent used in the reaction is not particularly limited as long as it does not adversely affect the reaction, but alcohols such as methanol and ethanol; ethers such as jetyl ether, tetrahydrofuran and dioxane; ethyl acetate, butyl acetate Esters such as: Aromatic hydrocarbons such as benzene, toluene and xylene; Halogenated hydrocarbons such as dichloromethane and chloroform; Aprotics such as acetonitrile, N, N-dimethylformamide, dimethyl sulfoxide, etc. Polar solvents may be mentioned, and these may be used in combination.
- alcohols such as methanol and ethanol
- ethers such as jetyl ether, tetrahydrofuran and dioxane
- ethyl acetate, butyl acetate Esters such as: Aromatic hydrocarbons such as benzene, toluene and xylene; Halogen
- This reaction may be carried out at 30-60 ° C by first adding halogen to triarylphosphine to prepare a triarylphosphine monohalogen adduct, then adding compound (4) and tertiary amine. preferable.
- the reaction time is not particularly limited, but is usually 10 minutes to 12 hours, preferably 0.5 to 8 hours.
- the reaction between compound (5) and primary amine is carried out in the presence of an acid.
- the reaction is preferably performed under non-aqueous conditions.
- This reaction is a reaction that opens the aziridine ring
- the group attached to the aziridine ring was conventionally considered to be an electron-withdrawing group (J. Org. Chem. 68, 5160, 2003). )
- This reaction can be ring-opened even when an electron donating group such as an alkyl group such as a methyl group or an aralkyl group such as a benzyl group is bonded to a nitrogen atom.
- acids can be used, for example, hydrochloric acid, hydrobromic acid, sulfuric acid And inorganic acids such as nitric acid; organic acids such as formic acid, acetic acid, p-toluenesulfonic acid, methanesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, and trifluoroacetic acid.
- organic acids such as formic acid, acetic acid, p-toluenesulfonic acid, methanesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, and trifluoroacetic acid.
- sulfonic acid acids Particularly preferred is methanesulfonic acid.
- the amount of acid used is not particularly limited, but is preferably 1 to: especially preferably 4 to 6 moles per mole of compound (5)!
- primary amines examples include lower alkylamines such as methylamine and ethylamine; aralkylamines such as benzylamine; aralkylamines such as aline and naphthylamine; Methylamine is preferred.
- the amount of primary amine used is preferably 3 to 20 mol, and more preferably 5 to 7 mol, per 1 mol of compound (5).
- the solvent used in the reaction is not particularly limited as long as it does not adversely influence the reaction, but amides such as N-methylpyrrolidone, N, N dimethylformamide, N, N dimethylacetamide; alcohols such as methanol and ethanol These solvents may be used, and these may be used in combination.
- reaction temperature is not specifically limited, Preferably it is 50 to 200 degreeC, Most preferably, it is 100. C ⁇ 120. C.
- the reaction time is not particularly limited, but is usually 0.5 to 40 hours, preferably 1 to 12 hours.
- the racemic compound (6) can be led to the optically active substance (7) by a general optical resolution method.
- compound (6) is reacted with an optical resolving agent such as (+)-di-p-toluoyl D tartaric acid (hereinafter referred to as “(+)-DTTA”) to obtain a mixture of diastereomeric salts, and then the desired mixture.
- the diastereomeric salt of is precipitated and separated.
- the optical resolution is carried out in a solvent, but the solvent used is not limited as long as it is inert to diastereomeric salts.
- alcohols such as methanol, ethanol and isopropanol
- hydrocarbons such as hexane, benzene and toluene
- halogeno hydrocarbons such as methylene chloride and chloroform
- ketones such as acetone and methyl ethyl ketone
- water Etc water
- optical resolution agent used in the reaction examples include (+) DTTA, dibenzoyltartaric acid, etc. Examples thereof include active tartaric acid and derivatives thereof, preferably (+)-DTTA.
- the amount of the optical resolving agent used is preferably 0.5 to 1.2 mol, particularly preferably 1 mol, relative to compound (6).
- the obtained diastereomeric salt can be isolated by a known method such as filtration or centrifugation, and optical purity can be increased by recrystallization.
- a known method such as filtration or centrifugation, and optical purity can be increased by recrystallization.
- an ester type such as ethyl acetate
- a halogen type solvent such as methylene chloride, preferably dissolved in ethyl acetate, and dissolved once by heating and stirring at a temperature between room temperature and the boiling point of the solvent for 0.5 to 9 hours. After that, crystals can be precipitated, purified by cooling and drying.
- the diastereomeric salt obtained is treated with a base such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc., and then extracted with a solvent using toluene or the like to make an optically active substance. Can do.
- a base such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc.
- the benzylamine derivative or a salt thereof can be produced, for example, according to the following method using the optically active form (7) of the ethylenediamine derivative as a production intermediate.
- R 1 represents a lower alkyl group, an aryl group or an aralkyl group
- R 3 represents a lower alkyl group or an optionally substituted aryl group or aralkyl group
- R 4 represents R 5 represents an optionally substituted lower alkyl group
- R 5 represents a lower alkyl group, an aryl group, an aralkyl group, or an optionally substituted amino group
- X 3 and X 4 represent Represents a hydrogen atom or a halogen atom
- X 5 represents a halogen atom
- the optically active substance (7) is reacted with an acid and a ride (9) in the presence of a base such as sodium hydroxide and the like to obtain a compound (10), and further to the compound (10),
- the acid halide (11) is reacted in the presence of a tertiary amine such as triethylamine to give an amidy compound (12).
- the compound (12) is oxidized with an oxidizing agent such as sodium periodate in the presence of a ruthenium catalyst to obtain a mixture of the compounds (13) and (14), and the resulting mixture is further oxidized.
- Aldehyde ( 14) by reacting the compound (14) with the compound (19) by acting a reducing agent such as sodium triacetoxyborohydride in the presence of an acid, the benzylamine derivative represented by the general formula (20) or Can lead to its salt.
- the lower alkyl group of the lower alkyl group is the same straight chain having 1 to 6 carbon atoms as described above Or a branched alkyl group is mentioned, Preferably they are a methyl group and an ethyl group.
- the group that can be substituted with a lower alkyl group include 1 to 3 halogen atoms similar to those described above, and preferably a fluorine atom.
- Specific examples of the lower alkyl group which may have a substituent include a monofluoromethyl group, a difluoromethyl group, a trifluoromethyl group, and a 2,2,2-trifluoroethyl group.
- the lower alkyl group represented by R 5 the same linear or branched alkyl group having 1 to 6 carbon atoms, or a cycloalkyl group having a carbon number of 3 to 7.
- the cycloalkyl group include a cyclopropyl group, a cyclopropylmethyl group, a cyclobutylmethyl group, a cyclopropylethyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group.
- the aryl group represented by R 5 includes the same aryl group having 6 to 14 carbon atoms as described above, and is preferably a phenol group.
- the aralkyl group is the same as C as described above. —C
- the amino group may have a substituent represented by R 5 , and examples of the amino group include an amino group, a lower alkylamino group, a di-lower alkylamino group, and a phenolamino group.
- examples of the lower alkyl group that can be substituted for the amino group include a linear or branched alkyl group having 1 to 6 carbon atoms, and a cycloalkyl group having 3 to 7 carbon atoms.
- alkyl-substituted amino group examples include a methylamino group, an ethylamino group, an n-propylamino group, an isopropylamino group, an n-butylamino group, an n pentylamino group, a cyclopropylamino group, a dimethylamino group, and a diamino group.
- examples include an ethylamino group and a di-n-propylamino group.
- R 5 is preferably an aryl group, particularly a phenyl group.
- Examples of the halogen atom represented by X 3 to X 5 include the same halogen atoms as described above, and a chlorine atom is preferable.
- the salt of the benzylamine derivative is not particularly limited as long as it is a pharmaceutically acceptable salt, but an acid addition salt such as hydrochloride, sulfate, nitrate, hydrobromide, p-toluenesulfonic acid, and the like. Examples thereof include salts, methanesulfonate, fumarate, hibenzate, succinate, tartrate, lactate and the like, and hibenzate and tartrate are preferred.
- the benzylamine derivative or a salt thereof includes a solvate thereof. Further, both optically active substances and mixtures thereof are included.
- the benzylamine derivative (20) obtained as described above can be isolated and purified by known methods such as concentration, concentration under reduced pressure, solvent extraction, filtration, crystallization, recrystallization, and various chromatography. Can do. Further, for example, a desired acid is added after being dissolved in an organic solvent such as a chlorine type such as methylene chloride or black form; an ether type such as ether, tetrahydrofuran or dioxane, or an ester type such as ethyl acetate, preferably ethyl acetate. It can be isolated as an acid addition salt.
- an organic solvent such as a chlorine type such as methylene chloride or black form
- an ether type such as ether, tetrahydrofuran or dioxane
- ester type such as ethyl acetate, preferably ethyl acetate. It can be isolated as an acid addition salt.
- Examples of the acid used in the reaction include hydrochloric acid, sulfuric acid, nitric acid, hydrofluoric acid, ⁇ -toluenesulfonic acid, methanesulfonic acid, fumaric acid, hibenzic acid, succinic acid, tartaric acid, and lactic acid. is there.
- the acid is preferably used in an amount of 1 to 1.5 mol with respect to 1 mol of the compound (20).
- the obtained acid addition salt is alkalinized with a base in the presence of an organic solvent such as ethyl acetate, and then subjected to salt exchange by adding a desired acid to the organic layer, so that the optical addition salt has a higher optical purity.
- High acid addition salts can be obtained.
- examples of the acid used for the reaction include the same acids as described above, and tartaric acid is preferable.
- examples of the base used in the reaction include inorganic bases such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium hydroxide and potassium hydroxide; organic bases such as triethylamine and diisopropylethylamine. Of these, potassium carbonate is preferred.
- the property of the acid for acid salt formation is not specifically limited, it is desirable to use it, dissolving in alcoholic solvents, such as methanol and ethanol.
- the temperature during acid addition salt formation Depending on the solvent used, the temperature is preferably from 0 ° C. to the boiling point of the solvent for 0.5 to 72 hours.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
Abstract
Disclosed is a novel compound useful as a production intermediate for benzylamine derivatives. Also disclosed is a method for producing such a compound. Specifically disclosed is a method for producing an ethylenediamine derivative represented by the general formula (6) below or a salt thereof. (6) (In the formula, R1 represents a lower alkyl group, an aryl group or an aralkyl group; R2 represents a lower alkyl group or an alkenyl group; R3 represents a lower alkyl group, an optionally substituted aryl group or an aralkyl group; and Ar represents an optionally substituted aryl group.)
Description
エチレンジァミン誘導体及びその製造方法 Ethylenediamine derivative and method for producing the same
技術分野 Technical field
[0001] 本発明は、ベンジルァミン誘導体の製造中間体として有用な新規化合物及びその 製造方法に関する。 [0001] The present invention relates to a novel compound useful as an intermediate for the production of benzylamine derivatives and a method for producing the same.
背景技術 Background art
[0002] 次の一般式 (A)で表されるベンジルァミン誘導体は、優れたタキキュン拮抗作用、 特にサブスタンス P拮抗作用、ニューロキュン A及び Bに対する拮抗作用を有し、過 敏性腸症候群 (IBS : Irritable Bowel Syndrome)、疼痛、不安、閉塞性気管支 疾患、頭痛、嘔吐等の疾患の治療に有用であることが知られている (特許文献 1参照 [0002] The benzylamine derivative represented by the following general formula (A) has excellent tachycun antagonism, particularly substance P antagonism, antagonism against neurocun A and B, and irritable bowel syndrome (IBS: Irritable Bowel Syndrome), known to be useful for the treatment of diseases such as pain, anxiety, obstructive bronchial disease, headache, vomiting (see Patent Document 1)
) o ) o
[0003] [化 1] [0003] [Chemical 1]
[0004] (式中の番号及び式中の記号は特許文献 1による) [0004] (Numbers in the formula and symbols in the formula are according to Patent Document 1)
ベンジルァミン誘導体の合成法としては、特許文献 1に、市販のベンズアルデヒドを 出発原料に、 2—メチルァミノペンテノール誘導体を経由して製造する方法が開示さ れている。し力しながら、特許文献 1に記載の合成法は、多くの工程が必要で、よりェ 業的に優れた製造法の開発が求められていた。 As a method for synthesizing a benzylamine derivative, Patent Document 1 discloses a process for producing a benzaldehyde derivative from a commercially available benzaldehyde via a 2-methylaminopentenol derivative. However, the synthesis method described in Patent Document 1 requires many steps, and the development of a manufacturing method that is industrially superior has been demanded.
特許文献 1:国際公開第 2005Z012248号パンフレット Patent Document 1: International Publication No. 2005Z012248 Pamphlet
発明の開示 Disclosure of the invention
発明が解決しょうとする課題 Problems to be solved by the invention
[0005] 従って、本発明は、上記一般式 (A)で表されるベンジルァミン誘導体の製造に有 利な新規中間体及びその製造方法を提供することを目的とする。
課題を解決するための手段 [0005] Therefore, an object of the present invention is to provide a novel intermediate useful for the production of the benzylamine derivative represented by the general formula (A) and a method for producing the same. Means for solving the problem
[0006] 本発明者らは、上記課題を解決するため鋭意検討した結果、下記の一般式 (6)で 表わされるエチレンジァミン誘導体力 ベンジルァミン誘導体の製造中間体として極 めて有用であることを見出し、本発明を完成した。 [0006] As a result of diligent studies to solve the above-mentioned problems, the present inventors have found that the ethylenediamine derivative power represented by the following general formula (6) is extremely useful as an intermediate for producing benzylamine derivatives. The present invention has been completed.
[0007] すなわち、本発明は、次の式(5) That is, the present invention provides the following formula (5)
[0008] [化 2] [0008] [Chemical 2]
[0009] (式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R2は低級アルキ ル基又はアルケニル基を示し、 Arは置換基を有して 、てもよ 、ァリール基を示す) で表されるアジリジンィ匕合物に、第 1級ァミン (NH R3)を反応させることを特徴とする [Wherein, R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 2 represents a lower alkyl group or an alkenyl group, and Ar may have a substituent, which may be an aryl group; A primary amin (NH R 3 ) is reacted with the aziridine compound represented by
2 2
式 (6) Formula (6)
[0010] [化 3] [0010] [Chemical 3]
[0011] (式中、 R3は低級アルキル基、置換基を有していてもよいァリール基又はァラルキル 基を示し、
R2及び Arは前記と同義である) (Wherein R 3 represents a lower alkyl group, an aryl group or an aralkyl group which may have a substituent, R 2 and Ar are as defined above)
で表されるエチレンジァミン誘導体又はその塩の製造方法を提供するものである。 The manufacturing method of the ethylenediamine derivative represented by these, or its salt is provided.
[0012] また、本発明は、上記方法より得られた式 (6)で表されるエチレンジァミン誘導体又 はその塩を光学分割することを特徴とする式 (7) [0012] Further, the present invention provides an optically resolved formula (7) characterized by optically resolving an ethylenediamine derivative represented by the formula (6) obtained by the above method or a salt thereof.
[0013] [化 4] [0013] [Chemical 4]
[0014] (式中、 *は不斉炭素原子を示し、!^〜 及び Arは前記と同義である) で表される光学活性エチレンジァミン誘導体又はその塩の製造方法を提供するもの である。 (Wherein * represents an asymmetric carbon atom,! ^ To and Ar are as defined above), and a method for producing an optically active ethylenediamine derivative or a salt thereof.
[0015] また、本発明は、次の式(1) [0015] Further, the present invention provides the following formula (1)
[0016] [化 5] [0016] [Chemical 5]
O O
(1) (1)
Ar Ar
[0017] (式中、 X1はハロゲン原子を示し、 Arは前記と同義である) [Wherein X 1 represents a halogen atom, and Ar is as defined above]
で表されるハロアセチルァリールイ匕合物にグリニャール試薬 (R2MgX2)を反応させ た後、更に第 1級ァミン (NH R1)を反応させることを特徴とする、式 (4) The compound represented by the formula (4) is characterized by reacting a Grignard reagent (R 2 MgX 2 ) with a haloacetyl aryl compound represented by formula (4), and further reacting with a primary amine (NH R 1 ).
[0018] [化 6] [0018] [Chemical 6]
OHOH
R N (4) R N (4)
Ar Ar
で表される化合物又はその塩の製造方法を提供するものである。 The manufacturing method of the compound or its salt represented by these is provided.
[0020] また、本発明は、次の式 (4) [0020] Further, the present invention provides the following formula (4)
[0021] [化 7] [0021] [Chemical 7]
OH OH
R1直 (4) R 1 straight (4)
Ar Ar
[0022] (式中、 R R2及び Arは前記と同義である) [0022] (wherein, RR 2 and Ar are as defined above)
で表される化合物に、第 3級ァミンの存在下、トリアリールホスフィン及びハロゲンを反 応させることを特徴とする、式 (5) A compound represented by formula (5) is characterized by reacting triarylphosphine and halogen in the presence of a tertiary amine.
[0023] [化 8]
[0024] (式中
び Arは前記と同義である) [0023] [Chemical 8] [0024] (where And Ar is as defined above)
で表される化合物又はその塩の製造方法を提供するものである。 The manufacturing method of the compound or its salt represented by these is provided.
[0025] また、本発明化合物の製造工程中、次の式(2— 1)、(3— 1)、(4—1)、(5— 1)、 ( 6— 1)及び(7—1)で表される中間体ィ匕合物は新規である。従って、本発明は、次の 一般式 (2— 1) [0025] During the production process of the compound of the present invention, the following formulas (2-1), (3-1), (4-1), (5-1), (6-1) and (7-1) The intermediate compound represented by) is novel. Accordingly, the present invention provides the following general formula (2-1)
[0026] [化 9] [0026] [Chemical 9]
(2-1) (2-1)
[0027] (式中、 X1及び X2はハロゲン原子を示し、 X3及び X4は水素原子又はハロゲン原子を 示す) [0027] (wherein, X 1 and X 2 represent a halogen atom, and X 3 and X 4 represent a hydrogen atom or a halogen atom)
で表される化合物又はその塩を提供するものである。 Or a salt thereof.
また、本発明は、次の一般式 (3— 1) Further, the present invention provides the following general formula (3-1)
[0028] [化 10] [0028] [Chemical 10]
(3-1) (3-1)
[0029] (式中、 X3及び X4は前記と同義である) [Wherein X 3 and X 4 are as defined above]
で表される化合物又はその塩を提供するものである。 Or a salt thereof.
また、本発明は、次の一般式 (4— 1) Further, the present invention provides the following general formula (4-1)
で表される化合物又はその塩を提供するものである。 Or a salt thereof.
また、本発明は、次の一般式 (5— 1) Further, the present invention provides the following general formula (5-1)
[0032] [化 12] [0032] [Chemical 12]
(5-1) (5-1)
で表される化合物又はその塩を提供するものである。 Or a salt thereof.
[0034] また、本発明は、次の一般式 (6— 1) [0034] Further, the present invention provides the following general formula (6-1)
[0035] [化 13] [0035] [Chemical 13]
[0036] (式中、 R\ R3、 X3及び X4は前記と同義である) [0036] (wherein R \ R 3 , X 3 and X 4 are as defined above)
で表されるエチレンジァミン誘導体又はその塩を提供するものである c さらに、本発明は、次の一般式 (7— 1) In addition, the present invention provides the following general formula (7-1):
[0037] [化 14]
[0038] (式中
び *は前記と同義である) [0037] [Chemical 14] [0038] (where And * are as defined above)
で表される光学活性エチレンジァミン誘導体又はその塩を提供するものである。 発明の効果 The optically active ethylenediamine derivative represented by these, or its salt is provided. The invention's effect
[0039] 本発明によれば、エチレンジァミン誘導体又はその塩を製造中間体として用いるこ とにより、ベンジルァミン誘導体を少ない工程で効率良く製造することができ、工業的 製造に適している。また、本発明化合物であるエチレンジァミン誘導体は、これを光 学分割し晶析することで、極めて光学純度の高 、光学活性エチレンジァミン誘導体と して単離精製できるため、医薬品製造中間体として有用である。 [0039] According to the present invention, by using an ethylenediamine derivative or a salt thereof as a production intermediate, the benzylamine derivative can be efficiently produced with few steps, and is suitable for industrial production. In addition, the ethylenediamine derivative which is the compound of the present invention is useful as a pharmaceutical production intermediate because it can be isolated and purified as an optically active ethylenediamine derivative by optically resolving and crystallizing it. .
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
[0040] 式中、 R1 R2及び R3で示される低級アルキルとしては、炭素数 1〜6の直鎖又は分 岐鎖のアルキル基が挙げられ、例えばメチル基、ェチル基、プロピル基、イソプロピ ル基、ブチル基、 t ブチル基、ペンチル基、へキシル基等が挙げられる。これらのう ち、特にメチル基が好ましい。 [0040] In the formula, examples of the lower alkyl represented by R 1 R 2 and R 3 include a linear or branched alkyl group having 1 to 6 carbon atoms, such as a methyl group, an ethyl group, a propyl group, Examples include isopropyl group, butyl group, t-butyl group, pentyl group, hexyl group and the like. Of these, a methyl group is particularly preferred.
[0041] R1で示されるァリール基としては、炭素数 6〜14のァリール基が挙げられ、例えば フエニル基、ナフチル基等が挙げられる。 [0041] The aryl group represented by R 1 includes an aryl group having 6 to 14 carbon atoms, and examples thereof include a phenyl group and a naphthyl group.
[0042] R1及び R3で示されるァラルキル基としては、 C -C ーァリール—C -C アルキ [0042] The aralkyl group represented by R 1 and R 3 includes C 1 -C 6 -aryl-C 1 -C 4 alkyl.
6 14 1 6 ル基が挙げられ、例えばフエ-ルー C アルキル基、ナフチル C—C アルキル 6 14 1 6 group, such as ferro-C alkyl group, naphthyl C—C alkyl group
1-6 1 6 1-6 1 6
基等が挙げられる。これらのうち、特にべンジル基、フ ネチル基が好ましい。 Groups and the like. Of these, a benzyl group and a phenethyl group are particularly preferable.
式中、 R1としては、低級アルキル基が好ましぐ特にメチル基が好ましい。 In the formula, R 1 is preferably a lower alkyl group, and particularly preferably a methyl group.
[0043] R2で示されるァルケ-ル基としては、 C—Cの直鎖又は分岐鎖のァルケ-ル基が [0043] The alkenyl group represented by R 2 includes a C-C linear or branched alkenyl group.
2 6 2 6
挙げられ、例えばビニル基、ァリル基、ブテュル基、ペンテ-ル基、へキセニル基等 が挙げられる。これらのうち、特にァリル基が好ましい。 Examples thereof include a vinyl group, a aryl group, a butyr group, a pentyl group, and a hexenyl group. Of these, an aryl group is particularly preferable.
式中、 R2としては、アルケニル基が好ましぐ特にァリル基が好ましい。
[0044] R3で示される置換基を有して 、てもよ 、ァリール基としては、前記と同様の炭素数 6 〜 14のァリール基が挙げられる。ここでァリール基に置換し得る基としては、ハロゲン 原子、ニトロ基、低級アルキル基、低級アルコキシ基等の 1〜3個が挙げられる。ハロ ゲン原子としてはフッ素原子、塩素原子、臭素原子、ヨウ素原子等が挙げられる。低 級アルキル基としては、前記と同様の炭素数 1〜6の直鎖又は分岐鎖のアルキル基 が挙げられる。また、低級アルキコキシ基としては、炭素数 1〜6の直鎖又は分岐鎖 のアルコキシ基が挙げられ、例えばメトキシ基、エトキシ基、 n プロポキシ基、イソプ 口ポキシ基、 n—ブトキシ基、イソブトキシ基、 sec ブトキシ基、 tert ブトキシ基、 n ペンチルォキシ基、イソペンチルォキシ基、 n—へキシルォキシ基等が挙げられる 式中、 R3としては、低級アルキル基が好ましぐ特にメチル基が好ましい。 In the formula, R 2 is preferably an alkenyl group, particularly preferably an aryl group. [0044] Examples of the aryl group having the substituent represented by R 3 include aryl groups having 6 to 14 carbon atoms as described above. Examples of the group that can be substituted on the aryl group include 1 to 3 groups such as a halogen atom, a nitro group, a lower alkyl group, and a lower alkoxy group. Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom. Examples of the lower alkyl group include linear or branched alkyl groups having 1 to 6 carbon atoms as described above. Examples of the lower alkoxy group include linear or branched alkoxy groups having 1 to 6 carbon atoms, such as methoxy group, ethoxy group, n propoxy group, isopropyl group, n-butoxy group, isobutoxy group, sec butoxy group, tert butoxy group, n pentyloxy group, isopentyloxy group, n-hexyloxy group, and the like. In the formula, R 3 is preferably a lower alkyl group, and a methyl group is particularly preferable.
[0045] Arで示される置換基を有していてもよいァリール基としては、前記と同様の炭素数[0045] The aryl group optionally having a substituent represented by Ar has the same carbon number as described above.
6〜14のァリール基が挙げられ、好ましくはフエ-ル基である。ここで、ァリール基に 置換し得る基としては、前記と同様のハロゲン原子が挙げられ、好ましくは塩素原子 である。置換基の数は、 1〜3個であるが、好ましくは 2である。また置換位置は、好ま しくは 3位及び 4位である。 Examples thereof include 6 to 14 aryl groups, preferably a phenol group. Here, examples of the group that can be substituted on the aryl group include the same halogen atoms as described above, and preferably a chlorine atom. The number of substituents is 1 to 3, but preferably 2. The substitution positions are preferably the 3rd and 4th positions.
[0046] X1、 X2、 X3及び X4で示されるハロゲン原子としては、前記と同様のハロゲン原子が 挙げられ、好ましくは塩素原子、臭素原子である。 [0046] Examples of the halogen atom represented by X 1 , X 2 , X 3 and X 4 include the same halogen atoms as described above, preferably a chlorine atom and a bromine atom.
[0047] 式中 *は、付された炭素原子が不斉炭素原子であることを示す。本発明において、 不斉炭素の立体配置は R配置、 S配置のいずれでもよいが、 S配置であることが好ま しい。 [0047] In the formula, * indicates that the attached carbon atom is an asymmetric carbon atom. In the present invention, the configuration of the asymmetric carbon may be either the R configuration or the S configuration, but the S configuration is preferred.
[0048] エチレンジァミン誘導体の塩としては、薬学的に許容される塩であれば特に制限さ れないが、酸付加塩、例えば塩酸塩、硫酸塩、硝酸塩、臭化水素酸塩、 p トルエン スルホン酸塩、メタンスルホン酸塩、フマル酸塩、ヒベンズ酸塩、コハク酸塩、酒石酸 塩、乳酸塩等が挙げられる。また、本発明のエチレンジァミン誘導体又はその塩には 、それらの溶媒和物を含む。さらに、光学活性体及びそれらの混合物のいずれをも 含む。 [0048] The salt of the ethylenediamine derivative is not particularly limited as long as it is a pharmaceutically acceptable salt. However, acid addition salts such as hydrochloride, sulfate, nitrate, hydrobromide, p-toluenesulfonic acid, etc. Salts, methanesulfonate, fumarate, hibenzate, succinate, tartaric acid, lactate and the like. The ethylenediamine derivative or salt thereof of the present invention includes those solvates. Further, both optically active substances and mixtures thereof are included.
[0049] 本発明のエチレンジァミン誘導体又はその塩の製造方法は、次の反応式で示すこ
とができる。 [0049] The method for producing an ethylenediamine derivative or a salt thereof of the present invention is represented by the following reaction formula. You can.
[0050] [化 15] [0050] [Chemical 15]
(6) (7) (6) (7)
[0051] (式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R2は低級アルキ ル基又はァルケ-ル基を示し、 R3は低級アルキル基、置換基を有していてもよいァリ ール基又はァラルキル基を示し、 Arは置換基を有して 、てもよ 、ァリール基を示し、 X1及び X2はハロゲン原子を示し、 *は不斉炭素原子を示す) (Wherein R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 2 represents a lower alkyl group or an alkyl group, and R 3 has a lower alkyl group or a substituent. Ar may be an aryl group or an aralkyl group, Ar may have a substituent, may represent an aryl group, X 1 and X 2 represent a halogen atom, and * represents an asymmetric carbon atom. Show)
[0052] すなわち、ハロアセチルァリールイ匕合物(1)にグリニャール試薬を反応させた後、 更に第 1級ァミンを反応させて化合物 (4)を得る。次いで該化合物 (4)に第 3級ァミン の存在下、トリアリールホスフィン及びハロゲン原子を反応させてアジリジン化合物(5 )とし、該化合物(5)を第 1級ァミンにより開環させることにより本発明化合物(6)が得 られる。さらに、化合物 (6)を光学分割して所望のジァステレオマー塩を分離し、得ら れたジァステレオマー塩を塩基で処理することで光学活性体(7)が得られる。従って 、上記化合物(2)〜化合物(5)は、本発明化合物 (6)の製造中間体として有用であ る。なお、本発明の出発物質である一般式(1)で表される化合物は公知の化合物で
あり、例えば第 4版実験化学講座 19卷 (丸善)に記載の方法により、市販のァセトフエ ノン誘導体とハロゲン原子を反応させ、容易に合成できる。 [0052] That is, after reacting the haloacetyl aryl compound (1) with a Grignard reagent, further reacting with a primary ammine, a compound (4) is obtained. Next, the compound (4) is reacted with a triarylphosphine and a halogen atom in the presence of a tertiary amine to give an aziridine compound (5), and the compound (5) is ring-opened with the primary amine. Compound (6) is obtained. Furthermore, compound (6) is optically resolved to separate a desired diastereomeric salt, and the resulting diastereomeric salt is treated with a base to obtain optically active substance (7). Therefore, the compounds (2) to (5) are useful as production intermediates of the compound (6) of the present invention. The compound represented by the general formula (1) which is the starting material of the present invention is a known compound. For example, it can be easily synthesized by reacting a commercially available acetophenone derivative with a halogen atom according to the method described in the fourth edition, Experimental Chemistry Course 19 (Maruzen).
以下、各反応工程毎に説明する。 Hereinafter, each reaction step will be described.
[0053] ハロアセチルァリール化合物(1)とグリニャール試薬との反応は、ジェチルエーテ ル、テトラヒドロフラン、ジォキサン等のエーテル系溶媒中で行われる。 [0053] The reaction of the haloacetyl aryl compound (1) and the Grignard reagent is carried out in an ether solvent such as jetyl ether, tetrahydrofuran or dioxane.
グリニャール試薬の使用量は、化合物(1)に対して、当モル用いることが好ましい。 反応温度は特に限定されないが、通常— 110°C〜― 10°C、好ましくは— 80°C〜 40°Cである。 The Grignard reagent is preferably used in an equimolar amount with respect to compound (1). The reaction temperature is not particularly limited, but is usually −110 ° C. to −10 ° C., preferably −80 ° C. to 40 ° C.
反応時間は特に限定されないが、通常滴下終了〜 48時間、好ましくは 0. 5〜12 時間である。なお、本反応では、化合物(2)から誘導体(3)へと進行する。反応液中 では化合物(2)及び(3)の混合物となって 、ることも考えられるが、反応系を変えるこ となくそのまま次の反応に用いてもょ 、。 The reaction time is not particularly limited, but is usually from the end of dropping to 48 hours, preferably from 0.5 to 12 hours. In this reaction, the compound (2) proceeds to the derivative (3). In the reaction solution, it may be a mixture of compounds (2) and (3), but it can be used in the next reaction without changing the reaction system.
[0054] 上記反応により得られた化合物(2)及び(3)の混合物に第 1級ァミンを反応させる ことによりィ匕合物 (4)を得る。 [0054] The compound (4) is obtained by reacting the mixture of the compounds (2) and (3) obtained by the above reaction with a primary amine.
反応で用いる第 1級ァミンとしては、メチルァミン、ェチルァミン等の低級アルキルァ ミン;ベンジルァミン等のァラルキルァミン;ァ-リン、ナフチルァミン等のァリールアミ ンが挙げられ、好ましくは低級アルキルァミンであり、より好ましくはメチルァミンである 。ァミンの使用量は、化合物(2)及び(3)の混合物 1モルに対し、 1〜3モル用いるこ と力 S好ましく、特に 2〜2. 5モル用いることが好ましい。 Examples of the primary amine used in the reaction include lower alkylamines such as methylamine and ethylamine; aralkylamines such as benzylamine; and arylamines such as aline and naphthylamine. . The amount of amine used is preferably 1 to 3 moles, more preferably 2 to 2.5 moles per mole of the mixture of compounds (2) and (3).
反応で用いる溶媒としては、反応に悪影響を与えないものであれば特に限定され ないが、メタノール、エタノール等のアルコール系;ジェチルエーテル、テトラヒドロフ ラン、ジォキサン等のエーテル系;水等が挙げられ、これらを混合して用いてもよい。 反応温度は特に限定されないが、好ましくは室温〜 80°Cであり、特に好ましくは、 3 0°C〜60°Cである。 The solvent used in the reaction is not particularly limited as long as it does not adversely affect the reaction, and examples thereof include alcohols such as methanol and ethanol; ethers such as jetyl ether, tetrahydrofuran and dioxane; water and the like. These may be used in combination. The reaction temperature is not particularly limited, but is preferably room temperature to 80 ° C, particularly preferably 30 ° C to 60 ° C.
反応時間は特に限定されないが、通常 0. 5〜24時間、好ましくは 0. 5〜12時間で ある。 The reaction time is not particularly limited, but is usually 0.5 to 24 hours, preferably 0.5 to 12 hours.
[0055] アジリジンィ匕合物(5)の合成は、式 (4)で表わされる化合物に、第 3級ァミンの存在 下にトリアリールホスフィンとハロゲンを反応させることにより分子内環化反応が進行し
、アジリジン環が形成される。 [0055] The synthesis of the aziridine compound (5) involves the intramolecular cyclization reaction proceeding by reacting the compound represented by the formula (4) with triarylphosphine and halogen in the presence of a tertiary amine. An aziridine ring is formed.
反応で用いる第 3級ァミンとしては、トリメチルァミン、トリェチルァミン、トリ— n—ブ チルァミン、 N, N—ジメチルァ-リン等が挙げられ、好ましくはトリエチルァミンである 。塩基の使用量は、化合物(4) 1モルに対し、 2〜6モル用いることが好ましぐ特に 3 〜4モル用いることが好まし!/、。 Examples of the tertiary amine used in the reaction include trimethylamine, triethylamine, tri-n-butyramine, N, N-dimethylamine, and preferably triethylamine. The amount of the base used is preferably 2 to 6 mol, particularly preferably 3 to 4 mol, based on 1 mol of the compound (4)! /.
反応で用いるトリアリールホスフィンとしては、トリフエ-ルホスフィンが挙げられる。ま た、ハロゲンとしては、フッ素、塩素、臭素、ヨウ素が挙げられ、好ましくは臭素である 。トリアリールホスフィン及びハロゲンの使用量は、それぞれィ匕合物(4) 1モルに対し、 1〜3モル用いることが好ましぐ特に 1. 3〜2モル用いることが好ましい。 Examples of the triarylphosphine used in the reaction include triphenylphosphine. In addition, examples of the halogen include fluorine, chlorine, bromine and iodine, and bromine is preferable. The amount of triarylphosphine and halogen used is preferably 1 to 3 mol, particularly preferably 1.3 to 2 mol, per 1 mol of compound (4).
反応で用いる溶媒としては、反応に悪影響を与えないものであれば特に限定され ないが、メタノール、エタノール等のアルコール系;ジェチルエーテル、テトラヒドロフ ラン、ジォキサン等のエーテル系;酢酸ェチル、酢酸ブチル等のエステル系;ベンゼ ン、トルエン、キシレン等の芳香族炭化水素類;ジクロロメタン、クロ口ホルム等のハロ ゲン化炭化水素系;ァセトニトリル、 N, N—ジメチルホルムアミド、ジメチルスルホキシ ド等の非プロトン性極性溶媒が挙げられ、これらを混合して用いてもよい。好ましくは The solvent used in the reaction is not particularly limited as long as it does not adversely affect the reaction, but alcohols such as methanol and ethanol; ethers such as jetyl ether, tetrahydrofuran and dioxane; ethyl acetate, butyl acetate Esters such as: Aromatic hydrocarbons such as benzene, toluene and xylene; Halogenated hydrocarbons such as dichloromethane and chloroform; Aprotics such as acetonitrile, N, N-dimethylformamide, dimethyl sulfoxide, etc. Polar solvents may be mentioned, and these may be used in combination. Preferably
、酢酸ェチル、ァセトニトリル又はこれらの混合溶媒である。 , Ethyl acetate, acetonitrile, or a mixed solvent thereof.
本反応は、まずトリアリールホスフィンにハロゲンを添カ卩し、トリアリールホスフィン一 ハロゲン付加物を調製した後、化合物 (4)と第 3級ァミンを加え、 30〜60°Cで行うこ とが好ましい。 This reaction may be carried out at 30-60 ° C by first adding halogen to triarylphosphine to prepare a triarylphosphine monohalogen adduct, then adding compound (4) and tertiary amine. preferable.
反応時間は特に限定されないが、通常 10分〜 12時間、好ましくは 0. 5〜8時間で ある。 The reaction time is not particularly limited, but is usually 10 minutes to 12 hours, preferably 0.5 to 8 hours.
化合物(5)と第 1級ァミンとの反応は、酸の存在下で行なわれる。また反応は、非水 条件下で行うのが好まし 、。 The reaction between compound (5) and primary amine is carried out in the presence of an acid. The reaction is preferably performed under non-aqueous conditions.
本反応は、アジリジン環を開環する反応であるが、アジリジン環に結合する基は、従 来、電子吸引性基が最適と考えられていたが (J. Org. Chem. 68, 5160, 2003)、 本反応によれば、メチル基等のアルキル基、ベンジル基等のァラルキル基等の電子 供与性基が窒素原子に結合するものであっても開環させることができる。 Although this reaction is a reaction that opens the aziridine ring, the group attached to the aziridine ring was conventionally considered to be an electron-withdrawing group (J. Org. Chem. 68, 5160, 2003). ), This reaction can be ring-opened even when an electron donating group such as an alkyl group such as a methyl group or an aralkyl group such as a benzyl group is bonded to a nitrogen atom.
反応で用いる酸としては、公知の酸が使用でき、例えば、塩酸、臭化水素酸、硫酸
、硝酸等の無機酸;ギ酸、酢酸、 p トルエンスルホン酸、メタンスルホン酸、ベンゼン スルホン酸、カンファースルホン酸、トリフルォロ酢酸等の有機酸が挙げられ、好まし くはスルホン酸系の酸であり、特に好ましくはメタンスルホン酸である。酸の使用量は 特に限定されないが、化合物(5) 1モルに対し、 1〜: LOモル用いることが好ましぐ特 に 4〜6モル用いることが好まし!/、。 As the acid used in the reaction, known acids can be used, for example, hydrochloric acid, hydrobromic acid, sulfuric acid And inorganic acids such as nitric acid; organic acids such as formic acid, acetic acid, p-toluenesulfonic acid, methanesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, and trifluoroacetic acid. Preferred are sulfonic acid acids, Particularly preferred is methanesulfonic acid. The amount of acid used is not particularly limited, but is preferably 1 to: especially preferably 4 to 6 moles per mole of compound (5)!
第 1級ァミンとしては、メチルァミン、ェチルァミン等の低級アルキルァミン;ベンジル ァミン等のァラルキルァミン;ァ-リン、ナフチルァミン等のァリールァミン;ハロゲン化 ァリールァミン、低級アルキルァ-リン、低級アルコキシァ-リン、ニトロァ-リン等が 挙げられ、好ましくはメチルァミンである。第 1級ァミンの使用量は、化合物(5) 1モル に対し、 3〜20モルが好ましぐ特に 5〜7モルが好ましい。 Examples of primary amines include lower alkylamines such as methylamine and ethylamine; aralkylamines such as benzylamine; aralkylamines such as aline and naphthylamine; Methylamine is preferred. The amount of primary amine used is preferably 3 to 20 mol, and more preferably 5 to 7 mol, per 1 mol of compound (5).
反応で用いる溶媒としては、反応に悪影響を与えないものであれば特に限定され ないが、 N—メチルピロリドン、 N, N ジメチルホルムアミド、 N, N ジメチルァセト アミド等のアミド系;メタノール、エタノール等のアルコール系溶媒が挙げられ、これら を混合して用いてもよい。 The solvent used in the reaction is not particularly limited as long as it does not adversely influence the reaction, but amides such as N-methylpyrrolidone, N, N dimethylformamide, N, N dimethylacetamide; alcohols such as methanol and ethanol These solvents may be used, and these may be used in combination.
反応温度は特に限定されないが、好ましくは 50°C〜200°Cであり、特に好ましくは 100。C〜120。Cである。 Although reaction temperature is not specifically limited, Preferably it is 50 to 200 degreeC, Most preferably, it is 100. C ~ 120. C.
反応時間は特に限定されないが、通常 0. 5〜40時間、好ましくは 1〜12時間であ る。 The reaction time is not particularly limited, but is usually 0.5 to 40 hours, preferably 1 to 12 hours.
ラセミ体である化合物(6)は、一般的な光学分割方法により、光学活性体 (7)に導 くことができる。例えば、化合物(6)に(+ )—ジー p トルオイル D 酒石酸 (以下 、「( + )— DTTA」という。)等の光学分割剤を反応させて、ジァステレオマー塩の混 合物を得、次いで所望のジァステレオマー塩を析出させて分離する。光学分割は溶 媒中で行うが、使用する溶媒はジァステレオマー塩に対して不活性なものであれば 限定されない。例えばメタノール、エタノール、イソプロパノール等のアルコール系; へキサン、ベンゼン、トルエン等の炭化水素類;塩化メチレン、クロ口ホルム等のハロ ゲンィ匕炭化水素系;アセトン、メチルェチルケトン等のケトン類;水等を挙げることがで きる。 The racemic compound (6) can be led to the optically active substance (7) by a general optical resolution method. For example, compound (6) is reacted with an optical resolving agent such as (+)-di-p-toluoyl D tartaric acid (hereinafter referred to as “(+)-DTTA”) to obtain a mixture of diastereomeric salts, and then the desired mixture. The diastereomeric salt of is precipitated and separated. The optical resolution is carried out in a solvent, but the solvent used is not limited as long as it is inert to diastereomeric salts. For example, alcohols such as methanol, ethanol and isopropanol; hydrocarbons such as hexane, benzene and toluene; halogeno hydrocarbons such as methylene chloride and chloroform; ketones such as acetone and methyl ethyl ketone; water Etc.
反応で用いる光学分割剤としては、(+ ) DTTA、ジベンゾィル酒石酸等の光学
活性酒石酸及びその誘導体が挙げられ、好ましくは(+ )— DTTAである。光学分割 剤の使用量は、化合物(6)に対し、 0. 5〜1. 2モル用いることが好ましぐ特に 1モル 用いることが好ましい。 Examples of the optical resolution agent used in the reaction include (+) DTTA, dibenzoyltartaric acid, etc. Examples thereof include active tartaric acid and derivatives thereof, preferably (+)-DTTA. The amount of the optical resolving agent used is preferably 0.5 to 1.2 mol, particularly preferably 1 mol, relative to compound (6).
[0058] 得られたジァステレオマー塩は、濾過、遠心分離等の公知の方法により単離するこ とができ、さらに再結晶に付することにより、光学純度を上げることができる。例えば、 酢酸ェチル等のエステル系;塩化メチレン等のハロゲン系溶媒、好ましくは酢酸ェチ ルに溶解し、室温〜溶媒の沸点以下の温度で 0. 5〜9時間加熱攪拌することにより 一度溶解させた後結晶を析出させ、冷却濾過、乾燥を行い、精製することができる。 また、得られたジァステレオマー塩は、水酸化ナトリウム、水酸ィ匕カリウム、炭酸ナト リウム、炭酸カリウム等の塩基で処理した後、トルエン等を用いて溶媒抽出することに より光学活性体とすることができる。 [0058] The obtained diastereomeric salt can be isolated by a known method such as filtration or centrifugation, and optical purity can be increased by recrystallization. For example, an ester type such as ethyl acetate; a halogen type solvent such as methylene chloride, preferably dissolved in ethyl acetate, and dissolved once by heating and stirring at a temperature between room temperature and the boiling point of the solvent for 0.5 to 9 hours. After that, crystals can be precipitated, purified by cooling and drying. The diastereomeric salt obtained is treated with a base such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc., and then extracted with a solvent using toluene or the like to make an optically active substance. Can do.
ベンジルァミン誘導体又はその塩は、エチレンジァミン誘導体の光学活性体(7)を 製造中間体として使用して、例えば次の方法に従って製造できる。 The benzylamine derivative or a salt thereof can be produced, for example, according to the following method using the optically active form (7) of the ethylenediamine derivative as a production intermediate.
[0059] [化 16]
[0059] [Chemical 16]
R4. R 4 .
0 0H (8)0 0H (8)
[0060] (式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R3は低級アルキ ル基、置換基を有していてもよいァリール基又はァラルキル基を示し、 R4は置換基を 有していてもよい低級アルキル基を示し、 R5は低級アルキル基、ァリール基、ァラル キル基、又は置換基を有していてもよいアミノ基を示し、 X3及び X4は水素原子又は ハロゲン原子を示し、 X5はハロゲン原子を示す) (Wherein R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 3 represents a lower alkyl group or an optionally substituted aryl group or aralkyl group, and R 4 represents R 5 represents an optionally substituted lower alkyl group, R 5 represents a lower alkyl group, an aryl group, an aralkyl group, or an optionally substituted amino group, and X 3 and X 4 represent Represents a hydrogen atom or a halogen atom, and X 5 represents a halogen atom)
[0061] すなわち、光学活性体 (7)に、水酸ィ匕ナトリウム等の塩基の存在下で酸ノ、ライド(9) を反応させて化合物(10)とし、更に該化合物(10)に、トリェチルァミン等の第 3級ァ ミンの存在下で酸ハライド(11)を反応させてアミドィ匕合物(12)を得る。次いで、該化 合物(12)をルテニウム触媒の存在下、過ヨウ素酸ナトリウム等の酸化剤により酸化し て化合物(13)と(14)の混合物を得、得られた混合物を更に酸ィ匕してアルデヒド体(
14)とする。次いで、酸の存在下、ナトリウムトリァセトキシボロハイドライド等の還元剤 を作用させることにより、該化合物(14)と化合物(19)を反応させれば一般式 (20)で 表されるベンジルァミン誘導体又はその塩へ導くことができる。 [0061] That is, the optically active substance (7) is reacted with an acid and a ride (9) in the presence of a base such as sodium hydroxide and the like to obtain a compound (10), and further to the compound (10), The acid halide (11) is reacted in the presence of a tertiary amine such as triethylamine to give an amidy compound (12). Next, the compound (12) is oxidized with an oxidizing agent such as sodium periodate in the presence of a ruthenium catalyst to obtain a mixture of the compounds (13) and (14), and the resulting mixture is further oxidized. Aldehyde ( 14). Next, by reacting the compound (14) with the compound (19) by acting a reducing agent such as sodium triacetoxyborohydride in the presence of an acid, the benzylamine derivative represented by the general formula (20) or Can lead to its salt.
なお、 2H—スピロ [イソキノリン 1, 4,ーピペリジン ]—3 (4H)—オン(19)は、 1 ベンジルピペリジンー4 オン(15)と 2 フエ-ルァセタミド(16)を酸の存在下に反 応させて化合物(17)を得、これを単離した後、閉環させてスピロ化合物(18)とし、次 いで水素下に接触還元することにより得ることができる。 2H-spiro [isoquinoline 1,4, -piperidine] -3 (4H) -one (19) reacts with 1 benzylpiperidin-4-one (15) and 2 ferroacetamide (16) in the presence of acid. To obtain the compound (17), which is isolated and then closed to obtain the spiro compound (18), which is then obtained by catalytic reduction under hydrogen.
[0062] 式中、 R4で示される置換基を有して!/、てもよ!/、低級アルキル基の低級アルキル基と しては、前記と同様の炭素数 1〜6の直鎖又は分岐鎖のアルキル基が挙げられ、好 ましくはメチル基、ェチル基である。ここで低級アルキル基に置換し得る基としては、 前記と同様のハロゲン原子の 1〜3個が挙げられ、好ましくフッ素原子である。置換基 を有していてもよい低級アルキル基の具体例としては、モノフルォロメチル基、ジフル ォロメチル基、トリフルォロメチル基、 2, 2, 2—トリフルォロェチル基等が挙げられる [0062] In the formula, having a substituent represented by R 4 ! /, May be! /, And the lower alkyl group of the lower alkyl group is the same straight chain having 1 to 6 carbon atoms as described above Or a branched alkyl group is mentioned, Preferably they are a methyl group and an ethyl group. Examples of the group that can be substituted with a lower alkyl group include 1 to 3 halogen atoms similar to those described above, and preferably a fluorine atom. Specific examples of the lower alkyl group which may have a substituent include a monofluoromethyl group, a difluoromethyl group, a trifluoromethyl group, and a 2,2,2-trifluoroethyl group.
[0063] R5で示される低級アルキル基としては、前記と同様の炭素数 1〜6の直鎖もしくは 分岐鎖のアルキル基、又は炭素数 3〜7のシクロアルキル基が挙げられる。シクロア ルキル基としては、例えばシクロプロピル基、シクロプロピルメチル基、シクロブチルメ チル基、シクロプロピルェチル基、シクロペンチル基、シクロへキシル基、シクロヘプ チル基等が挙げられる。 [0063] As the lower alkyl group represented by R 5, the same linear or branched alkyl group having 1 to 6 carbon atoms, or a cycloalkyl group having a carbon number of 3 to 7. Examples of the cycloalkyl group include a cyclopropyl group, a cyclopropylmethyl group, a cyclobutylmethyl group, a cyclopropylethyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group.
[0064] R5で示されるァリール基としては、前記と同様の炭素数 6〜14のァリール基が挙げ られ、好ましくはフエ-ル基である、また、ァラルキル基としては、前記と同様の C—C [0064] The aryl group represented by R 5 includes the same aryl group having 6 to 14 carbon atoms as described above, and is preferably a phenol group. The aralkyl group is the same as C as described above. —C
6 ーァリール—C—C アルキル基が挙げられる。 6-aryl-C—C alkyl group.
14 1 6 14 1 6
[0065] R5で示される置換基を有して 、てもよ 、ァミノ基としては、アミノ基、低級アルキルァ ミノ基、ジ低級アルキルアミノ基、フエ-ルァミノ基が挙げられる。ここでァミノ基に置換 し得る低級アルキル基としては炭素数 1〜6の直鎖もしくは分岐鎖のアルキル基、又 は炭素数 3〜7のシクロアルキル基が挙げられる。アルキル置換アミノ基の具体例とし てはメチルァミノ基、ェチルァミノ基、 n—プロピルアミノ基、イソプロピルアミノ基、 n— ブチルァミノ基、 n ペンチルァミノ基、シクロプロピルアミノ基、ジメチルァミノ基、ジ
ェチルァミノ基、ジ n—プロピルアミノ基等が挙げられる。 [0065] The amino group may have a substituent represented by R 5 , and examples of the amino group include an amino group, a lower alkylamino group, a di-lower alkylamino group, and a phenolamino group. Here, examples of the lower alkyl group that can be substituted for the amino group include a linear or branched alkyl group having 1 to 6 carbon atoms, and a cycloalkyl group having 3 to 7 carbon atoms. Specific examples of the alkyl-substituted amino group include a methylamino group, an ethylamino group, an n-propylamino group, an isopropylamino group, an n-butylamino group, an n pentylamino group, a cyclopropylamino group, a dimethylamino group, and a diamino group. Examples include an ethylamino group and a di-n-propylamino group.
式中、 R5としては、ァリール基が好ましぐ特にフエニル基が好ましい。 In the formula, R 5 is preferably an aryl group, particularly a phenyl group.
[0066] X3〜X5で示されるハロゲン原子としては、前記と同様のハロゲン原子が挙げられ、 好ましくは塩素原子である。 [0066] Examples of the halogen atom represented by X 3 to X 5 include the same halogen atoms as described above, and a chlorine atom is preferable.
[0067] ベンジルァミン誘導体の塩としては、薬学的に許容される塩であれば特に制限され ないが、酸付加塩、例えば塩酸塩、硫酸塩、硝酸塩、臭化水素酸塩、 p—トルエンス ルホン酸塩、メタンスルホン酸塩、フマル酸塩、ヒベンズ酸塩、コハク酸塩、酒石酸塩 、乳酸塩等が挙げられ、ヒベンズ酸塩、酒石酸塩が好ましい。また、ベンジルァミン誘 導体又はその塩には、それらの溶媒和物を含む。さらに、光学活性体及びそれらの 混合物のいずれをも含む。 [0067] The salt of the benzylamine derivative is not particularly limited as long as it is a pharmaceutically acceptable salt, but an acid addition salt such as hydrochloride, sulfate, nitrate, hydrobromide, p-toluenesulfonic acid, and the like. Examples thereof include salts, methanesulfonate, fumarate, hibenzate, succinate, tartrate, lactate and the like, and hibenzate and tartrate are preferred. The benzylamine derivative or a salt thereof includes a solvate thereof. Further, both optically active substances and mixtures thereof are included.
[0068] 上記のようにして得られるベンジルァミン誘導体(20)は、例えば、濃縮、減圧濃縮 、溶媒抽出、濾過、晶析、再結晶、各種クロマトグラフィー等の公知の方法により単離 、精製することができる。また、例えばメチレンクロリド、クロ口ホルム等の塩素系;エー テル、テトラヒドロフラン、ジォキサン等のエーテル系、酢酸ェチル等のエステル系等 の有機溶媒、好ましくは酢酸ェチルに溶解した後、所望の酸を加えることによって酸 付加塩として単離することができる。反応で用いる酸としては、塩酸、硫酸、硝酸、臭 化水素酸、 ρ—トルエンスルホン酸、メタンスルホン酸、フマル酸、ヒベンズ酸、コハク 酸、酒石酸、乳酸等が挙げられ、好ましくはヒベンズ酸である。酸は、化合物(20) 1 モルに対し、 1〜1. 5モル用いることが好ましい。 [0068] The benzylamine derivative (20) obtained as described above can be isolated and purified by known methods such as concentration, concentration under reduced pressure, solvent extraction, filtration, crystallization, recrystallization, and various chromatography. Can do. Further, for example, a desired acid is added after being dissolved in an organic solvent such as a chlorine type such as methylene chloride or black form; an ether type such as ether, tetrahydrofuran or dioxane, or an ester type such as ethyl acetate, preferably ethyl acetate. It can be isolated as an acid addition salt. Examples of the acid used in the reaction include hydrochloric acid, sulfuric acid, nitric acid, hydrofluoric acid, ρ-toluenesulfonic acid, methanesulfonic acid, fumaric acid, hibenzic acid, succinic acid, tartaric acid, and lactic acid. is there. The acid is preferably used in an amount of 1 to 1.5 mol with respect to 1 mol of the compound (20).
[0069] さらに得られた酸付加塩は、酢酸ェチル等の有機溶媒の存在下、塩基によりアル カリ性とした後、有機層に所望の酸を加えることによって塩交換を行い、より光学純度 の高い酸付加塩を得ることができる。ここで、反応に用いる酸としては、上記と同様の 酸を挙げることができるが、好ましくは酒石酸である。反応に用いる塩基としては、炭 酸ナトリウム、炭酸カリウム、炭酸水素ナトリウム、炭酸水素カリウム、水酸ィ匕ナトリウム 、水酸ィ匕カリウム等の無機塩基;トリェチルァミン、ジイソプロピルェチルァミン等の有 機塩基が挙げられ、好ましくは炭酸カリウムである。 [0069] Further, the obtained acid addition salt is alkalinized with a base in the presence of an organic solvent such as ethyl acetate, and then subjected to salt exchange by adding a desired acid to the organic layer, so that the optical addition salt has a higher optical purity. High acid addition salts can be obtained. Here, examples of the acid used for the reaction include the same acids as described above, and tartaric acid is preferable. Examples of the base used in the reaction include inorganic bases such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium hydroxide and potassium hydroxide; organic bases such as triethylamine and diisopropylethylamine. Of these, potassium carbonate is preferred.
なお、酸塩形成のための酸の性状は特に限定されないが、メタノール、エタノール 等のアルコール系溶媒に溶解して用いるのが望ましい。また、酸付加塩形成時の温
度は、使用する溶媒にもよるが、 0°C〜溶媒の沸点以下で、 0. 5〜72時間行うのが 好ましい。 In addition, although the property of the acid for acid salt formation is not specifically limited, it is desirable to use it, dissolving in alcoholic solvents, such as methanol and ethanol. Also, the temperature during acid addition salt formation Depending on the solvent used, the temperature is preferably from 0 ° C. to the boiling point of the solvent for 0.5 to 72 hours.
実施例 Example
[0070] 次に本発明をさらに具体的に説明するために実施例を掲げる力 本発明は、以下の 実施例のみに限定されるものではない。 [0070] Next, the power of examples to further explain the present invention. The present invention is not limited to the following examples.
[0071] 参考例 1 2—ブロモー 1ー(3, 4—ジクロ口フエ-ル)エタノン(1,)の合成 [0071] Reference Example 1 Synthesis of 2-bromo-1- (3, 4-dichloro-phenyl) ethanone (1,)
[0072] [化 17] [0072] [Chemical 17]
[0073] 1— (3, 4—ジクロロフエ-ル)一エタノン 100kgをメタノール 200kgに溶解し、臭素 85kgを滴下、その後 25〜50°Cで 4時間攪拌した。減圧下、反応液を濃縮し、残查 に酢酸ェチルと硫酸ナトリウム水を加え抽出、有機層を水洗後、再び減圧下有機層 を濃縮し得られた残查にへキサンを加え結晶化させた。結晶を濾取、乾燥し 2—プロ モー 1— (3, 4—ジクロロフエ-ル)エタノン(1,) 105. 6kg (74. 5%)を得た。 [0073] 100 kg of 1- (3,4-dichlorophenol) monoethanone was dissolved in 200 kg of methanol, 85 kg of bromine was added dropwise, and then stirred at 25 to 50 ° C for 4 hours. The reaction solution was concentrated under reduced pressure, and the residue was extracted by adding ethyl acetate and aqueous sodium sulfate. The organic layer was washed with water, and the organic layer was again concentrated under reduced pressure, and hexane was added to the resulting residue for crystallization. . The crystals were collected by filtration and dried to give 2-promo 1- (3,4-dichlorophenol) ethanone (1, 1) 105.6 kg (74.5%).
化合物(1 ' ) Compound (1 ')
'H-NMR (400MHz, CDC13) δ :4. 38 (s, 2H) , 7. 59 (d, J = 8. 5Hz, 1H) , 7. 81 (dd, J = 2. 0, 8. 5Hz, 1H) , 8. 07 (d, J = 2. OHz, 1H) 'H-NMR (400MHz, CDC13) δ: 4.38 (s, 2H), 7.59 (d, J = 8.5Hz, 1H), 7.81 (dd, J = 2.0, 8.5Hz , 1H), 8. 07 (d, J = 2. OHz, 1H)
[0074] 実施例 1 (1ーブロモー 2— (3, 4—ジクロ口フエ-ル)ペントー 4ーェンー2—オール [0074] Example 1 (1-Bromo 2— (3, 4—Diclonal Mole) Pento 4 4-Yen 2-ol
(2,)及び 2—ァリルー2—(3, 4—ジクロロフヱ-ル)ォキシラン(3,)の製造 Production of (2,) and 2-arylu-2- (3,4-dichlorophenyl) oxysilane (3,)
[0075] [化 18] [0075] [Chemical 18]
[0076] 2 ブロモ 1— (3, 4 ジクロロフエ-ル)エタノン 65. Okgを THF 180kgに溶解 し、等モルのァリルマグネシウムブロマイド THF溶液を— 40°C以下で滴下し、そのま ま 3時間攪拌した。反応液に水と濃塩酸を加え 15分攪拌後静置し、有機層をとり(1 —ブロモー 2— (3, 4 ジクロロフエ-ノレ)ペントー 4 ェン一 2—ォーノレ(2,)と 2 ァ リルー2—(3, 4 ジクロ口フエ-ル)ォキシラン(3,)の混合物を得、そのまま次のェ 程に用いた。 [0076] 2 Bromo 1— (3,4 dichlorophenol) ethanone 65. Dissolve Okg in 180 kg of THF and add dropwise an equimolar amount of allylmagnesium bromide in THF at -40 ° C or lower for 3 hours. Stir. Water and concentrated hydrochloric acid were added to the reaction mixture, and the mixture was stirred for 15 minutes and allowed to stand, and the organic layer was taken (1—bromo-2- (3,4 dichlorophenol), pentone, 4-benzene-2-enole (2,) and 2 A mixture of Reru 2- (3,4 dichlorophole) oxysilane (3) was obtained and used as such in the next step.
[0077] 化合物(2') [0077] Compound (2 ')
'H-NMR (400MHz, CDC13) δ :2, 59 (s, 1H), 2.69(d, J = 7.0Hz, 2H), 3.71 (s, 2H), 5.10〜5.17(m, 2H), 5.53〜5.64 (m, 1H), 7.23(dd, J = 2.5, 8.5Hz, 1H), 7.44(d, J = 8.5Hz, 1H), 7.55(d, J = 2.5Hz, 1H) [0078] 化合物(3') 'H-NMR (400MHz, CDC13) δ: 2, 59 (s, 1H), 2.69 (d, J = 7.0Hz, 2H), 3.71 (s, 2H), 5.10-5.17 (m, 2H), 5.53 ~ 5.64 (m, 1H), 7.23 (dd, J = 2.5, 8.5Hz, 1H), 7.44 (d, J = 8.5Hz, 1H), 7.55 (d, J = 2.5Hz, 1H) [0078] Compound (3 ')
'H-NMR (400MHz, CDC13) δ :2.59(dd, J = 7.0, 15.0Hz, 1H), 2.71( d, J = 5.5Hz, 1H), 2.87(ddt, J = 6.5, 15.0, 1.0Hz, 1H), 3.01(d, J = 5 .5Hz, 1H), 5.09〜5.17(m, 2H), 5.68〜5.80 (m, 1H), 7.21(dd, J = 2. 0, 8.5Hz, 1H), 7.40(d, J = 8.5Hz, 1H), 7.46(d, J = 2.0Hz, 1H) 'H-NMR (400MHz, CDC13) δ: 2.59 (dd, J = 7.0, 15.0Hz, 1H), 2.71 (d, J = 5.5Hz, 1H), 2.87 (ddt, J = 6.5, 15.0, 1.0Hz, 1H), 3.01 (d, J = 5.5Hz, 1H), 5.09 to 5.17 (m, 2H), 5.68 to 5.80 (m, 1H), 7.21 (dd, J = 2.0, 8.5Hz, 1H), 7.40 (d, J = 8.5Hz, 1H), 7.46 (d, J = 2.0Hz, 1H)
[0079] 実施例 2 2— (3, 4 ジクロ口フエ-ル)ー1—(メチルァミノ)ペントー 4ーェンー2— オール 塩酸塩 (4,)の製造 Example 2 2— Production of (3, 4 Diclonal Membrane) -1— (Methylamino) pento 4-ene-2-ol Hydrochloride (4,)
[0080] [化 19] [0080] [Chemical 19]
実施例 1で得られた有機層(1ーブロモー 2— (3, 4ージクロ口フエ-ル)ペントー 4 —ェン 2—オール(2,)と 2 ァリル一 2— (3, 4 ジクロロフエ-ル)ォキシラン(3, )の混合物にメタノール 77. Okgと 40%モノメチルァミン水溶液を 190kgを力卩ぇ約 50 °Cで 2時間加熱攪拌した。減圧にて濃縮後、反応液にトルエン 100kgを加え、濃塩 酸にて約 pHlとし結晶を析出させ、濾取乾燥し、 2- (3, 4 ジクロロフエ-ル)— 1 —(メチルァミノ)ペントー 4ーェン 2 オール 塩酸塩(4,)を 69.2kg (96. 1%)
[0082] 化合物 (4') Organic layer obtained in Example 1 (1-bromo-2- (3,4-dichlorophale) pento 4-en-2-ol (2,) and 2-aryl 2- (3,4 dichlorophenol) Mix 77. Okg of methanol and 190 kg of 40% aqueous monomethylamine with a mixture of oxysilane (3,) and stir for 2 hours at about 50 ° C. After concentration under reduced pressure, add 100 kg of toluene to the reaction mixture. Crystals are precipitated to about pH 1 with concentrated hydrochloric acid, collected by filtration, and dried. 69.2 kg (96) of 2- (3, 4 dichlorophenol) — 1 — (methylamino) pento 4-en-2-ol hydrochloride (4,) . 1%) [0082] Compound (4 ')
'H-NMR (400MHz, DMSO-d ) δ :2.47(t, J=4.5Hz, 3H), 2.62 (d, J 'H-NMR (400MHz, DMSO-d) δ: 2.47 (t, J = 4.5Hz, 3H), 2.62 (d, J
6 6
=7.0Hz, 2H), 3.21〜3.30 (m, 1H), 3.33〜3.45 (m, 1H), 4.94〜5.0 2(m, 2H), 5.53〜5.65 (m, 1H), 6.32(s, 1H), 7.46(dd, J = 2.0, 8.5Hz , 1H), 7.64(d, J = 8.5Hz, 1H), 7.71(d, J = 2.0Hz, 1H), 8.19(brs, 1H) , 8.68(brs, 1H) = 7.0Hz, 2H), 3.21 to 3.30 (m, 1H), 3.33 to 3.45 (m, 1H), 4.94 to 5.0 2 (m, 2H), 5.53 to 5.65 (m, 1H), 6.32 (s, 1H) , 7.46 (dd, J = 2.0, 8.5Hz, 1H), 7.64 (d, J = 8.5Hz, 1H), 7.71 (d, J = 2.0Hz, 1H), 8.19 (brs, 1H), 8.68 (brs, 1H)
[0083] 実施例 3 2 ァリル—2— (3, 4 ジクロ口フエ-ル)ー1 メチルアジリジン(5,)の 製造 Example 3 Production of 2 aryl-2- (3, 4 Dichlorophle) -1 methylaziridine (5,)
[0084] [化 20] [0084] [Chemical 20]
[0085] トリフ -ルホスフィン 132kgとァセトニトリル 200kgを混合し、攪拌しながら室温以 下にて臭素 81kgを滴下、約 50°Cにて 15分攪拌した。反応液を減圧下にて濃縮した 後、酢酸ェチルを 300kg加えトリフエ-ルホシフィンジブロマイド—酢酸ェチル溶液と した後、 2— (3, 4 ジクロロフエ-ル)— 1— (メチルァミノ)ペントー 4 ェン— 2—ォ ール 塩酸塩(4,)を 100kgとトリェチルァミン 154kgを加え 35〜50。Cで 1時間カロ熱 攪拌した。室温にて反応液に水を加え 15分攪拌後静置し有機層を取り、水層を酢酸 ェチルで抽出し有機層と合わせた後、飽和食塩水で洗浄した。有機層を減圧にて濃 縮し、残查にへキサンを加え析出する固形物を濾別した。へキサン溶液を濃縮し 2— ァリル— 2— (3, 4 ジクロロフエ-ル)— 1—メチルアジリジン(5,)71.2kg (純度 92 .3%、収率 87.3%)を油状物として得た。なお、これをそのまま次の反応に用いた。 [0085] 132 kg of trifluorophosphine and 200 kg of acetonitrile were mixed, 81 kg of bromine was added dropwise at room temperature or lower with stirring, and the mixture was stirred at about 50 ° C for 15 minutes. After concentrating the reaction solution under reduced pressure, 300 kg of ethyl acetate was added to make a triphenylphosphine dibromide-ethyl acetate solution, and then 2— (3,4 dichlorophenyl) — 1— (methylamino) pento 4 — 2—ol 100 kg of hydrochloride (4) and 154 kg of triethylamine 35-50. The mixture was stirred with C for 1 hour. Water was added to the reaction solution at room temperature, and the mixture was stirred for 15 minutes and allowed to stand to take an organic layer. The aqueous layer was extracted with ethyl acetate, combined with the organic layer, and washed with saturated brine. The organic layer was concentrated under reduced pressure, hexane was added to the residue, and the precipitated solid was filtered off. The hexane solution was concentrated to give 7-aryl-2- (3,4-dichlorophenol) -1-methylaziridine (5,) 71.2 kg (purity 92.3%, yield 87.3%) as an oil. This was directly used for the next reaction.
[0086] 化合物(5') [0086] Compound (5 ')
'H-NMR (400MHz, CDC13) δ :1.49 (s, 0.35H), 1.60 (s, 0.65H), 1.9 5(s, 0.35H), 2.05 (s, 1.95H), 2.06 (s, 0.65H), 2.17(dd, J = 7.0, 14.
OHz, 0.65H), 2.53(dd, J = 6.5, 16. OHz, 0.35H), 2.62(s, 1.05H), 2 .73(dd, J = 7.0, 14. OHz, 0.65H), 2.84(dd, J = 6.5, 16. OHz, 0.35H) , 4.92〜5.05 (m, 2H), 5.59〜5.74 (m, 1H), 7.16(dd, J = 2.0, 8.5Hz, 0.65H), 7.20(dd, J = 2.0, 8.5Hz, 0.35H), 7.34(d, J = 8.5Hz, 0.35H ), 7.39(d, J = 2. OHz, 0.65H), 7.42(d, J = 8.5Hz, 0.65H), 7.46 (d, J =2. OHz, 0.35H) 'H-NMR (400MHz, CDC13) δ: 1.49 (s, 0.35H), 1.60 (s, 0.65H), 1.9 5 (s, 0.35H), 2.05 (s, 1.95H), 2.06 (s, 0.65H ), 2.17 (dd, J = 7.0, 14. OHz, 0.65H), 2.53 (dd, J = 6.5, 16. OHz, 0.35H), 2.62 (s, 1.05H), 2.73 (dd, J = 7.0, 14. OHz, 0.65H), 2.84 ( dd, J = 6.5, 16. OHz, 0.35H), 4.92 to 5.05 (m, 2H), 5.59 to 5.74 (m, 1H), 7.16 (dd, J = 2.0, 8.5Hz, 0.65H), 7.20 (dd , J = 2.0, 8.5Hz, 0.35H), 7.34 (d, J = 8.5Hz, 0.35H), 7.39 (d, J = 2. OHz, 0.65H), 7.42 (d, J = 8.5Hz, 0.65H ), 7.46 (d, J = 2. OHz, 0.35H)
[0087] 実施例 4 2— (3, 4—ジクロロフエ-ル)— N1, N2—ジメチルペントー 4—ェン— 1, 2 ージァミン (6,)の製造 Example 4 2— (3,4-Dichlorophenol) — Production of N 1 , N 2 —Dimethylpentose 4—En—1,2 Diamine (6,)
[0088] [化 21] [0088] [Chemical 21]
[0089] N—メチルピロリドン 280kgにメタンスルホン酸 140kgと 40%モノメチルァミン一メタ ノール溶液 230kgを加え、攪拌下先に得られた粗アジリジン化合物(5' )を加え、 10 0〜115°Cで加熱攪拌した。冷却後、反応液にトルエンと水を加え 25%水酸ィ匕ナトリ ゥム水溶液でアルカリ性とした後抽出した。有機層を取り飽和食塩水で洗浄後、有機 層を減圧にて濃縮し、 2— (3, 4—ジクロロフエ-ル)— N1, N2—ジメチルペント— 4 —ェン— 1, 2—ジァミン (ラセミ体)(6,)として残查を得た。 [0089] 140 kg of methanesulfonic acid and 230 kg of 40% monomethylamine-methanol solution were added to 280 kg of N-methylpyrrolidone, and the crude aziridine compound (5 ') obtained earlier was added with stirring, and the temperature was 100 to 115 ° C. And stirred with heating. After cooling, toluene and water were added to the reaction mixture, and the mixture was made alkaline with 25% aqueous sodium hydroxide and extracted. The organic layer is taken and washed with saturated brine, and the organic layer is concentrated under reduced pressure. 2— (3,4-Dichlorophenol) —N 1 , N 2 —Dimethylpent— 4 —En— 1, 2— The residue was obtained as diamin (racemate) (6).
[0090] 化合物(6') [0090] Compound (6 ')
'H-NMR (400MHz, CDC13) δ :1.38(brs, 2H), 2.19 (s, 3H), 2.38 (s, 3 H), 2.45〜2.62 (m, 2H), 2, 72(d, J=12. OHz, 1H), 2.81(d, J=12. OH z, 1H), 7.26(dd, J = 2.0, 8.5Hz, 1H), 7.41(d, J = 8.5Hz, 1H), 7.53 (d , J = 2. OHz, 1H) 'H-NMR (400MHz, CDC13) δ: 1.38 (brs, 2H), 2.19 (s, 3H), 2.38 (s, 3H), 2.45 ~ 2.62 (m, 2H), 2, 72 (d, J = 12. OHz, 1H), 2.81 (d, J = 12.OH z, 1H), 7.26 (dd, J = 2.0, 8.5Hz, 1H), 7.41 (d, J = 8.5Hz, 1H), 7.53 (d , J = 2. OHz, 1H)
[0091] 実施例 5 (s)— 2— (3, 4—ジクロロフエ-ル)一 N1, N2—ジメチルペント一 4—ェンExample 5 (s) — 2— (3, 4-dichlorophenyl) 1 N 1 , N 2 — dimethylpent 4—
— 1, 2—ジァミン( + )—ジトルオイル酒石酸塩(7,)の製造 — 1, 2—Diamine (+) — Manufacture of ditoluoyl tartrate (7,)
[0093] (1)得られた残查にイソプロパノール 840kgをカ卩え、約 45°Cで(+ )—ジトルオイル酒 石酸 115kgを加え 1時間攪拌し析出した結晶をろ取し、 (s)-2-(3, 4—ジクロロフ ェ-ル)— N1, N2—ジメチルペントー 4—ェン— 1, 2—ジァミン( + )—ジトルオイル 酒石酸塩 ·1型結晶 156.2kg (純度 93.4%)を得た。 [0093] (1) Add 840 kg of isopropanol to the resulting residue, add 115 kg of (+)-ditoluoyltartaric acid at about 45 ° C, stir for 1 hour, and collect the precipitated crystals by filtration. 2- (3, 4-Jikurorofu E - Le) - N 1, N 2 - dimethyl pentose 4 E down - 1, 2- Jiamin (+) - ditoluoyltartaric acid salt, 1 type crystal 156.2Kg (purity 93.4% )
[0094] 1型結晶 [0094] Type 1 crystal
'H-NMR (400MHz, DMSO-d ) δ :2.02(s, 3Η), 2.35 (s, 6H), 2.43〜 'H-NMR (400MHz, DMSO-d) δ: 2.02 (s, 3Η), 2.35 (s, 6H), 2.43〜
6 6
2.56 (m, 5H), 3.19(d, J=13.0Hz, 1H), 3.33(d, J=13.0Hz, 1H), 4.9 4〜5.01 (m, 2H), 5.36〜5.48 (m, 1H), 5.60 (s, 2H), 7.28(d, J = 2. OH z, 4H), 7.35(dd, J = 2.0, 8.5Hz, 1H), 7.61〜7.65 (m, 2H), 7.80 (d, J =8.0Hz, 4H) 2.56 (m, 5H), 3.19 (d, J = 13.0Hz, 1H), 3.33 (d, J = 13.0Hz, 1H), 4.9 4 to 5.01 (m, 2H), 5.36 to 5.48 (m, 1H), 5.60 (s, 2H), 7.28 (d, J = 2. OH z, 4H), 7.35 (dd, J = 2.0, 8.5Hz, 1H), 7.61-7.65 (m, 2H), 7.80 (d, J = (8.0Hz, 4H)
[0095] (2)得られた結晶を 45〜55°Cに加熱した酢酸ェチル 550kgに加え、 50〜55°Cに て 2時間攪拌し、室温に冷却した後ろ取、乾燥し、 (s)-2-(3, 4—ジクロロフヱニル )— N1, N2—ジメチルペントー 4—ェン— 1, 2—ジァミン( + )—ジトルオイル酒石酸 塩 2型結晶 53. lkg (34. 1%)を得た。 [0095] (2) The obtained crystals were added to 550 kg of ethyl acetate heated to 45 to 55 ° C., stirred at 50 to 55 ° C. for 2 hours, cooled to room temperature, dried, and (s) -2- (3,4-Dichlorophenyl) —N 1 , N 2 —Dimethylpento 4-ene— 1,2-Diamine (+) —Ditoluoyltartaric acid Type 2 crystals 53. lkg (34. 1%) Obtained.
[0096] 2型結晶 [0096] Type 2 crystal
'H-NMR (400MHz, DMSO-d ) δ :2.02(s, 3Η), 2.35 (s, 6H), 2.43〜 'H-NMR (400MHz, DMSO-d) δ: 2.02 (s, 3Η), 2.35 (s, 6H), 2.43〜
6 6
2.56 (m, 5H), 3.19(d, J=13.0Hz, 1H), 3.33(d, J=13.0Hz, 1H), 4.9 4〜5.01 (m, 2H), 5.36〜5.48 (m, 1H), 5.60 (s, 2H), 7.28(d, J = 8. OH z, 4H), 7.35(dd, J = 2.0, 8.5Hz, 1H), 7.61〜7.65 (m, 2H), 7.80 (d, J =8.0Hz, 4H)
2.56 (m, 5H), 3.19 (d, J = 13.0Hz, 1H), 3.33 (d, J = 13.0Hz, 1H), 4.9 4 to 5.01 (m, 2H), 5.36 to 5.48 (m, 1H), 5.60 (s, 2H), 7.28 (d, J = 8. OH z, 4H), 7.35 (dd, J = 2.0, 8.5Hz, 1H), 7.61-7.65 (m, 2H), 7.80 (d, J = (8.0Hz, 4H)
Claims
請求の範囲 The scope of the claims
次の式(5) The following formula (5)
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R2は低級アルキ ル基又はアルケニル基を示し、 Arは置換基を有して 、てもよ 、ァリール基を示す) で表されるアジリジンィ匕合物に、第 1級ァミン (NH R3)を反応させることを特徴とする (In the formula, R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 2 represents a lower alkyl group or an alkenyl group, Ar has a substituent, and may represent an aryl group) A primary amine (NH R 3 ) is reacted with the aziridine compound represented by
2 2
式 (6) Formula (6)
[化 2] [Chemical 2]
(式中、 R3は低級アルキル基、置換基を有していてもよいァリール基又はァラルキル 基を示し、 R\ R2及び Arは前記と同義である) (Wherein R 3 represents a lower alkyl group, an aryl group or an aralkyl group which may have a substituent, and R \ R 2 and Ar are as defined above)
で表されるエチレンジァミン誘導体又はその塩の製造方法。 The manufacturing method of the ethylenediamine derivative represented by these, or its salt.
[2] R1が低級アルキル基である請求項 1記載の製造方法。 [2] The production method according to claim 1, wherein R 1 is a lower alkyl group.
[3] R2がァルケ-ル基である請求項 1又は 2記載の製造方法。 [3] The production method according to claim 1 or 2, wherein R 2 is an alkenyl group.
[4] 第 1級ァミンが低級アルキルァミンである請求項 1〜3の 、ずれか 1項記載の製造方 法。 [4] The method according to any one of claims 1 to 3, wherein the primary amine is a lower alkylamine.
[5] Arがフ -ル基である請求項 1〜4の 、ずれか 1項記載の製造方法。 [5] The process according to any one of claims 1 to 4, wherein Ar is a full group.
[6] 反応がスルホン酸系の酸の存在下に行われる請求項 1〜5のいずれか 1項記載の製 造方法。 [6] The production method according to any one of claims 1 to 5, wherein the reaction is carried out in the presence of a sulfonic acid acid.
[7] 次の一般式 (6— 1) [7] The following general formula (6— 1)
(6-1) (6-1)
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R3は低級アルキ ル基、置換基を有していてもよいァリール基又はァラルキル基を示し、 X3及び X4は水 素原子又はハロゲン原子を示す) (In the formula, R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 3 represents a lower alkyl group, an aryl group or an aralkyl group which may have a substituent, and X 3 and X 4 represent (Represents hydrogen atom or halogen atom)
で表されるエチレンジァミン誘導体又はその塩。 An ethylenediamine derivative represented by the formula:
[8] 請求項 1〜6のいずれか 1項記載の方法により得られた式 (6)で表される:^ [8] Represented by the formula (6) obtained by the method according to any one of claims 1 to 6: ^
ァミン誘導体又はその塩を光学分割することを特徴とする式 (7) Formula (7) characterized by optical resolution of amin derivative or its salt
[化 4] [Chemical 4]
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R2は低級アルキ ル基又はァルケ-ル基を示し、 R3は低級アルキル基、置換基を有していてもよいァリ ール基又はァラルキル基を示し、 Arは置換基を有して 、てもよ 、ァリール基を示し、 *は不斉炭素原子を示す) (In the formula, R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 2 represents a lower alkyl group or an alkyl group, and R 3 may have a lower alkyl group or a substituent. An aryl group or an aralkyl group, Ar may have a substituent, may represent an aryl group, and * represents an asymmetric carbon atom)
で表される光学活性エチレンジァミン誘導体又はその塩の製造方法。 The manufacturing method of the optically active ethylenediamine derivative represented by these, or its salt.
[9] 光学分割が、(+ )—ジ—p—トルオイル D—酒石酸を用いて行われる請求項 8記 載の製造方法。 [9] The production method according to claim 8, wherein the optical resolution is performed using (+)-di-p-toluoyl D-tartaric acid.
[10] 次の一般式(7— 1) [10] The following general formula (7-1)
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R3は低級アルキ ル基、置換基を有していてもよいァリール基又はァラルキル基を示し、 X3及び X4は水 素原子又はハロゲン原子を示し、 *は不斉炭素原子を示す) (In the formula, R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 3 represents a lower alkyl group, an aryl group or an aralkyl group which may have a substituent, and X 3 and X 4 represent Represents a hydrogen atom or a halogen atom, and * represents an asymmetric carbon atom)
で表される光学活性エチレンジァミン誘導体又はその塩。 Or an optically active ethylenediamine derivative or a salt thereof.
[11] 酒石酸又は酒石酸誘導体とのジァステレオマー塩である請求項 10記載の光学活性 エチレンジァミン誘導体の塩。 11. The salt of an optically active ethylene diamine derivative according to claim 10, which is a diastereomeric salt with tartaric acid or a tartaric acid derivative.
[12] 立体配置が S配置である請求項 10又は 11に記載の光学活性エチレンジァミン誘導 体又はその塩。 12. The optically active ethylenediamine derivative or a salt thereof according to claim 10 or 11, wherein the steric configuration is the S configuration.
[13] 式(5)で表される化合物が、次の式 (4) [13] The compound represented by formula (5) is represented by the following formula (4):
[化 6] [Chemical 6]
OH OH
(4) (Four)
R' R '
Ar Ar
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R2は低級アルキ ル基又はアルケニル基を示し、 Arは置換基を有して 、てもよ 、ァリール基を示す) で表される化合物に、第 3級ァミンの存在下、トリアリールホスフィン及びハロゲンを反 応させることにより得られるものである請求項 1〜6のいずれか 1項記載の製造方法。 (In the formula, R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 2 represents a lower alkyl group or an alkenyl group, Ar has a substituent, and may represent an aryl group) The production method according to any one of claims 1 to 6, which is obtained by reacting a compound represented by the formula: triarylphosphine and halogen in the presence of a tertiary amine.
[14] 次の一般式(5— 1) [14] The following general formula (5-1)
(5-1) (5-1)
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 X3及び X4は水 素原子又はハロゲン原子を示す) (Wherein R 1 represents a lower alkyl group, an aryl group or an aralkyl group, and X 3 and X 4 represent a hydrogen atom or a halogen atom)
で表される化合物又はその塩。 Or a salt thereof.
[15] 式 (4)で表される化合物力 次の式(1) [15] Compound power represented by formula (4)
(式中、 X1はハロゲン原子を示し、 Arは置換基を有していてもよいァリール基を示す ) (In the formula, X 1 represents a halogen atom, Ar represents an aryl group which may have a substituent)
で表されるハロアセチルァリールイ匕合物にグリニャール試薬 (R2MgX2)を反応させ た後、更に第 1級ァミン (NH R1)を反応させることにより得られるものである請求項 1 2. A compound obtained by reacting a Grignard reagent (R 2 MgX 2 ) with a haloacetyl aryl compound represented by the formula ( 1 ) above, followed by further reacting with a primary amine (NH R 1 ).
2 2
3記載の製造方法。 3. The production method according to 3.
[16] 次の一般式(2— 1) [16] The following general formula (2-1)
[化 9] [Chemical 9]
(2-1) (2-1)
(式中、 X1及び X2はハロゲン原子を示し、 X3及び X4は水素原子又はハロゲン原子を 示す) (Wherein X 1 and X 2 represent halogen atoms, and X 3 and X 4 represent hydrogen atoms or halogen atoms)
で表される化合物又はその塩。 Or a salt thereof.
[18] 次の一般式 (4 1) [18] The following general formula (4 1)
[化 11] [Chemical 11]
(4-1) (4-1)
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 X3及び X4は水 素原子又はハロゲン原子を示す) (Wherein R 1 represents a lower alkyl group, an aryl group or an aralkyl group, and X 3 and X 4 represent a hydrogen atom or a halogen atom)
で表される化合物又はその塩。 Or a salt thereof.
[19] 次の式(1) [19] The following formula (1)
(式中、 X1はハロゲン原子を示し、 Arは置換基を有していてもよいァリール基を示す ) (In the formula, X 1 represents a halogen atom, Ar represents an aryl group which may have a substituent)
で表されるハロアセチルァリールイ匕合物にグリニャール試薬 (R2MgX2)を反応させ た後、更に第 1級ァミン (NH R1)を反応させることを特徴とする、式 (4) The compound represented by the formula (4) is characterized by reacting a Grignard reagent (R 2 MgX 2 ) with a haloacetyl aryl compound represented by formula (4), and further reacting with a primary amine (NH R 1 ).
2 2
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R2は低級アルキ ル基又はアルケニル基を示し、 Arは置換基を有して 、てもよ 、ァリール基を示す) で表される化合物又はその塩の製造方法。 (In the formula, R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 2 represents a lower alkyl group or an alkenyl group, Ar has a substituent, and may represent an aryl group) The manufacturing method of the compound represented by these, or its salt.
次の式 (4) The following formula (4)
(式中、 R1は低級アルキル基、ァリール基又はァラルキル基を示し、 R2は低級アルキ ル基又はアルケニル基を示し、 Arは置換基を有して 、てもよ 、ァリール基を示す) で表される化合物に、第 3級ァミンの存在下、トリアリールホスフィン及びハロゲンを反 応させることを特徴とする、式 (5) (In the formula, R 1 represents a lower alkyl group, an aryl group or an aralkyl group, R 2 represents a lower alkyl group or an alkenyl group, Ar has a substituent, and may represent an aryl group) A compound represented by formula (5) is characterized by reacting triarylphosphine and halogen in the presence of a tertiary amine.
[化 15] [Chemical 15]
(式中、 R R2及び Arは前記と同義である) (Wherein, RR 2 and Ar are as defined above)
で表される化合物又はその塩の製造方法。
The manufacturing method of the compound represented by these, or its salt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-205324 | 2005-07-14 | ||
JP2005205324A JP2008273841A (en) | 2005-07-14 | 2005-07-14 | Ethylenediamine derivative and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007007828A1 true WO2007007828A1 (en) | 2007-01-18 |
Family
ID=37637210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/313933 WO2007007828A1 (en) | 2005-07-14 | 2006-07-13 | Ethylenediamine derivative and method for producing same |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2008273841A (en) |
TW (1) | TW200744990A (en) |
WO (1) | WO2007007828A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7838580B2 (en) | 2006-12-12 | 2010-11-23 | Clariant Finance (Bvi) Limited | Salts of alkyl esters of carboxyethyl(alkyl)phosphinic acid |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS595171A (en) * | 1982-06-14 | 1984-01-12 | インペリアル・ケミカル・インダストリ−ズ・ピ−エルシ− | Triazole derivatives, manufacture and bactericide and plant growth regulant containing same |
JP2003504362A (en) * | 1999-07-09 | 2003-02-04 | サノフィ−サンテラボ | Method for producing 2- (2-arylmorpholin-2-yl) ethanol derivative and intermediate |
WO2005012248A1 (en) * | 2003-07-31 | 2005-02-10 | Zeria Pharmaceutical Co., Ltd. | Benzylamine derivative |
-
2005
- 2005-07-14 JP JP2005205324A patent/JP2008273841A/en active Pending
-
2006
- 2006-07-13 WO PCT/JP2006/313933 patent/WO2007007828A1/en active Application Filing
- 2006-07-14 TW TW095125896A patent/TW200744990A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS595171A (en) * | 1982-06-14 | 1984-01-12 | インペリアル・ケミカル・インダストリ−ズ・ピ−エルシ− | Triazole derivatives, manufacture and bactericide and plant growth regulant containing same |
JP2003504362A (en) * | 1999-07-09 | 2003-02-04 | サノフィ−サンテラボ | Method for producing 2- (2-arylmorpholin-2-yl) ethanol derivative and intermediate |
WO2005012248A1 (en) * | 2003-07-31 | 2005-02-10 | Zeria Pharmaceutical Co., Ltd. | Benzylamine derivative |
Non-Patent Citations (2)
Title |
---|
MINIEJEW C. ET AL.: "alpha-Phenylselanyl imines: preparation of beta-phenylselanyl amines and original synthesis of allylaziridines", TETRAHEDRON, vol. 61, no. 2, 2005, pages 447 - 456, XP004667889 * |
SHIBATA I. ET AL.: "Simple synthetic method of allyl- and vinyl-epoxides by allylation of carbonyl groups with allylic tins catalyzed by PbI2-HMPA", CHEMISTRY LETTERS, no. 6, 1998, pages 533 - 534, XP003007228 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7838580B2 (en) | 2006-12-12 | 2010-11-23 | Clariant Finance (Bvi) Limited | Salts of alkyl esters of carboxyethyl(alkyl)phosphinic acid |
Also Published As
Publication number | Publication date |
---|---|
TW200744990A (en) | 2007-12-16 |
JP2008273841A (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5813535B2 (en) | Production method of acyldiamine | |
JP2008239629A (en) | Novel polymorph of venlafaxine hydrochloride and method for preparing it | |
US7563904B2 (en) | Synthesis intermediates useful for preparing zolmitriptan | |
TWI291959B (en) | Process for preparing granisetron | |
TW200940525A (en) | Process for the preparation of 6-substituted-1-(2H)-isoquinolinones | |
JP2020502077A (en) | R-6-hydroxy-8- [1-hydroxy-2- [2- (4-methoxyphenyl) -1,1-dimethylethylaminoethyl] -2H-1,4-benzoxazin-3 (4H) -one Improved process for producing hydrochloride | |
JP7113098B2 (en) | Method for producing heterocyclideneacetamide derivative | |
JP6830569B1 (en) | Method for Producing Heterocyclidene Acetamide Derivative | |
JP2005511668A (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and process for their preparation | |
TW201343642A (en) | Processes for preparing rivaroxaban | |
WO2007004735A1 (en) | Method for producing 4(3h)-quinazolinone derivative | |
WO2015111085A2 (en) | Processes for the preparation of eltrombopag and pharmaceutically acceptable salts, solvates and intermediates thereof | |
WO2012169468A1 (en) | Method for producing cyclopentanone compound, and intermediate compound | |
WO2020171073A1 (en) | Method for producing benzazepine derivative and intermediate of same | |
US9745264B2 (en) | Method for preparing silodosin and intermediate thereof | |
WO2007007828A1 (en) | Ethylenediamine derivative and method for producing same | |
WO2006132424A1 (en) | Process for production of 4(3h)-quinazolinone derivative | |
WO2014008639A1 (en) | Method for preparing indacaterol | |
JPWO2016158737A1 (en) | Process for producing 1- (4-hydroxyphenyl) -4- (4-trifluoromethoxyphenoxy) piperidine or a salt thereof | |
JP4045722B2 (en) | Amine compounds, intermediates, production methods and optical resolution agents | |
WO1995011879A1 (en) | Process for producing acid-addition salt of z-isomer of triphenylethylene compound | |
EP2181997A1 (en) | A process for the preparation of tadalafil | |
JP4714921B2 (en) | Production method of pimobendan and its intermediate | |
KR101686087B1 (en) | Process for Production of Optically Active Indoline Derivatives or Salts Thereof | |
JP7320113B2 (en) | Method for producing heterocyclideneacetamide derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06781053 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |